Bullfrog ai and lieber institute for brain development collaboration identifies novel drug targets for neuropsychiatric disorders

Gaithersburg, md., may 16, 2024 (globe newswire) -- bullfrog ai holdings, inc. (nasdaq: bfrg; bfrgw) ("bullfrog ai" or the "company"), a technology-enabled drug discovery company using artificial intelligence (ai) and machine learning to enable the successful discovery and development of pharmaceuticals and biologics, today announced significant advancements in its collaboration with the lieber institute for brain development (libd), including the identification of potential drug targets for multiple neuropsychiatric conditions.
BFRG Ratings Summary
BFRG Quant Ranking